As of 2025-02-13, the Relative Valuation of Aldeyra Therapeutics Inc (ALDX) is (9.31) USD. This relative valuation is based on P/E multiples. With the latest stock price at 6.03 USD, the upside of Aldeyra Therapeutics Inc based on Relative Valuation is -254.5%.
The range of the Relative Valuation is (9.40) - (11.58) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.5x - 16.5x | 14.5x |
| Forward P/E multiples | 5.1x - 15.4x | 10.2x |
| Fair Price | (9.40) - (11.58) | (9.31) |
| Upside | -256.1% - -292.3% | -254.5% |
| Date | P/E |
| 2025-02-07 | -7.88 |
| 2025-02-06 | -7.98 |
| 2025-02-05 | -7.59 |
| 2025-02-04 | -7.11 |
| 2025-02-03 | -6.87 |
| 2025-01-31 | -6.97 |
| 2025-01-30 | -7.18 |
| 2025-01-29 | -6.89 |
| 2025-01-28 | -6.95 |
| 2025-01-27 | -6.69 |
| 2025-01-24 | -6.81 |
| 2025-01-23 | -6.69 |
| 2025-01-22 | -6.69 |
| 2025-01-21 | -6.50 |
| 2025-01-17 | -6.43 |
| 2025-01-16 | -6.35 |
| 2025-01-15 | -6.68 |
| 2025-01-14 | -6.25 |
| 2025-01-13 | -6.34 |
| 2025-01-10 | -6.57 |
| 2025-01-08 | -6.79 |
| 2025-01-07 | -6.79 |
| 2025-01-06 | -7.01 |
| 2025-01-03 | -7.25 |
| 2025-01-02 | -6.94 |
| 2024-12-31 | -6.63 |
| 2024-12-30 | -6.67 |
| 2024-12-27 | -6.57 |
| 2024-12-26 | -6.67 |
| 2024-12-24 | -6.32 |
| 2024-12-23 | -6.37 |
| 2024-12-20 | -6.49 |
| 2024-12-19 | -6.46 |
| 2024-12-18 | -6.49 |
| 2024-12-17 | -7.09 |
| 2024-12-16 | -6.73 |
| 2024-12-13 | -6.51 |
| 2024-12-12 | -6.66 |
| 2024-12-11 | -7.14 |
| 2024-12-10 | -7.03 |
| 2024-12-09 | -6.95 |
| 2024-12-06 | -6.94 |
| 2024-12-05 | -6.58 |
| 2024-12-04 | -6.59 |
| 2024-12-03 | -6.30 |
| 2024-12-02 | -6.41 |
| 2024-11-29 | -6.51 |
| 2024-11-27 | -6.57 |
| 2024-11-26 | -6.38 |
| 2024-11-25 | -6.61 |